Amgen repatha denmark?

Yes. Repatha (evolocumab) is available in Denmark. It’s a prescription injectable from Amgen and is EU-approved.

- Indications (EU label, typical use): to lower LDL-C in adults with primary hyperlipidemia or heterozygous familial hypercholesterolemia (as an add-on to diet and maximally tolerated statin therapy), and to reduce the risk of major cardiovascular events in adults with established ASCVD. There are also pediatric indications for certain forms of familial hypercholesterolemia, depending on the exact label.
- Access in Denmark: Availability depends on prescription and regional reimbursement decisions. A cardiologist or lipid specialist can assess whether you qualify and can arrange access.
- Dosing (common options): 140 mg subcutaneously every 2 weeks, or 420 mg subcutaneously once monthly.
- How to proceed: Talk to your GP or a specialist (e.g., cardiologist or lipid clinic) to see if Repatha is appropriate and if it can be covered under Danish healthcare. They can handle prescription and any necessary reimbursement approvals.
- Quick notes: It’s stored in the fridge (2–8°C) before use and is injected subcutaneously.

If you want, I can help look up the current Danish reimbursement criteria or locate a nearby specialist. What would you like to know more about?